These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6148250)

  • 1. Inhibition of synaptosomal [3H]noradrenaline uptake by beta-adrenoceptor blocking drugs: influence of lipophilicity.
    Street JA; Walsh A
    Eur J Pharmacol; 1984 Jul; 102(2):315-24. PubMed ID: 6148250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of beta-adrenoceptor blocking agents on the turnover rate of cardiac and splenic noradrenaline in rats.
    Alexandre JM; Chevillard C
    Br J Pharmacol; 1980 May; 69(1):35-40. PubMed ID: 6103727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
    McDevitt DG; Brown HC; Carruthers SG; Shanks RG
    Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of lipid solubility on the sperm immobilizing effect of beta-adrenoceptor blocking drugs.
    Hong CY; Turner P
    Br J Clin Pharmacol; 1982 Aug; 14(2):269-72. PubMed ID: 6125206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced inhibition of guinea pig platelet aggregation unrelated to their beta-adrenolytic actions.
    Iwamura M; Ishimori T; Makino M; Yasuda K; Izumi A; Himori N
    Jpn J Pharmacol; 1983 Feb; 33(1):219-26. PubMed ID: 6135813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose kinetics of oral propranolol, metoprolol, atenolol, and sotalol: relation to lipophilicity.
    Ochs HR; Greenblatt DJ; Arendt RM; Schäfer-Korting M; Mutschler E
    Arzneimittelforschung; 1985; 35(10):1580-2. PubMed ID: 2866772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The uptake and overflow of radiolabelled beta-adrenoceptor blocking agents by the isolated vas deferens of the rat.
    Lewis MJ
    Br J Pharmacol; 1977 Aug; 60(4):595-600. PubMed ID: 20192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-adrenoceptor antagonists and human sperm motility.
    Curtis-Prior PB; Gadd AL
    J Pharm Pharmacol; 1990 Mar; 42(3):220-2. PubMed ID: 1974626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of beta-adrenoceptor antagonists as modulators of drug metabolism: effect of lipophilicity on microsomal phase I and II reactions.
    Ahokas JT; Davies C; Ravenscroft PJ
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):103S-105S. PubMed ID: 6146333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian phase dependency of the effects of different beta-receptor blocking drugs on motor activity of rats. Importance of drug lipophilicity.
    Lemmer B; Neumann G
    Arzneimittelforschung; 1987 Mar; 37(3):321-5. PubMed ID: 2885007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B
    Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Betaxolol, a beta(1)-adrenoceptor antagonist, reduces Na(+) influx into cortical synaptosomes by direct interaction with Na(+) channels: comparison with other beta-adrenoceptor antagonists.
    Chidlow G; Melena J; Osborne NN
    Br J Pharmacol; 2000 Jun; 130(4):759-66. PubMed ID: 10864881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of nicotine-induced relaxation of the bovine retractor penis muscle by beta-adrenoceptor antagonists.
    Klinge E; Alaranta S; Nissinen R; Sjöstrand NO
    Pharmacol Res; 1992; 25(4):353-61. PubMed ID: 1357642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat.
    Lemmer B; Winkler H; Ohm T; Fink M
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jul; 330(1):42-9. PubMed ID: 2864639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The surface activity and self-association of some beta-adrenoceptor blocking agents in aqueous solution.
    Attwood D; Agarwal SP
    J Pharm Pharmacol; 1979 Jun; 31(6):392-5. PubMed ID: 39139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interactivities with lipid membranes differentially characterize selective and nonselective beta1-blockers.
    Mizogami M; Takakura K; Tsuchiya H
    Eur J Anaesthesiol; 2010 Sep; 27(9):829-34. PubMed ID: 20601889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the relationship between the inhibition of thrombin stimulated aggregation and thromboxane formation in isolated platelets treated with beta-adrenoceptor blocking drugs.
    Nosál R; Jancinová V; Petríková M
    Thromb Res; 1992 Dec; 68(4-5):333-44. PubMed ID: 1363256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol inhibits nonexocytotic noradrenaline release in myocardial ischemia.
    Richardt G; Lumpp U; Haass M; Schömig A
    Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):50-5. PubMed ID: 2314483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of beta-adrenoceptor blocking properties of sotalol, oxprenolol, propranolol and pindolol on rabbit intestinal smooth muscle.
    Salimi M
    Pharmacology; 1975; 13(5):441-7. PubMed ID: 1802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.